Trials / Completed
CompletedNCT03068481
Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study in healthy adult males is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The purpose of this study in patients with Parkinson's disease is to investigate safety and pharmacokinetics of single and multiple oral doses of KDT-3594. The exploratory efficacy of KDT-3594 will also be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KDT-3594 | Oral administration |
| DRUG | Placebo | Oral administration |
Timeline
- Start date
- 2017-02-20
- Primary completion
- 2018-08-13
- Completion
- 2018-08-13
- First posted
- 2017-03-01
- Last updated
- 2019-04-01
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03068481. Inclusion in this directory is not an endorsement.